021-51111890
购物车（）
sales@molnova.cn
N-Formyl-Met-Ala-Ser
CAS No. 17351-32-5
N-Formyl-Met-Ala-Ser ( —— )
产品货号. M30371 CAS No. 17351-32-5
N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称N-Formyl-Met-Ala-Ser
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
-
产品描述N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number17351-32-5
-
分子量335.38
-
分子式C12H21N3O6S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (298.17 mM)
-
SMILES——
-
化学全称Sequence:Foemyl-{Met}{Ala}{Ser}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Gluten Exorphin A5
Gluten Exorphin A5 是小麦麸质的片段，具有神经保护作用。Gluten Exorphin A5 不仅在周围神经系统中而且在中枢神经系统中产生多种作用。
-
SLLK, Control Peptid...
SLLK is a control peptide for LSKL.
-
Probucol disuccinate
普罗布考是一种抗高血脂化合物，最初是为了通过增加低密度脂蛋白分解代谢率来降低血液中胆固醇水平来治疗冠状动脉疾病而开发的。
